Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price rises 6.08% to Rs 102.49
- August 28, 2026
- Posted by: Harsh Piplani
- Category: News
Morepen Laboratories Share Price rose to Rs 102.49 today, up 6.08% from the previous close of Rs 96.62, while the company’s market capitalisation stood at Rs 5,314.6 Cr. The move places Morepen Laboratories Ltd. in focus among Pharma-related Stock Market Today searches, even though the supplied data confirms the price event but does not establish a company-specific catalyst. The share price rise is also relevant because the stock opened at Rs 96.84, touched a day high of Rs 102.9 and saw turnover of Rs 6.11 Cr. Univest tracks the move through a factual lens, combining price action, valuation and sector context without adding unsupported reasons.
For readers following Morepen Laboratories Share Price Today, the key point is straightforward: the stock closed materially above the previous close and near the day high. In Morepen Laboratories Stock News and Morepen Laboratories News Today searches, that combination is enough to keep the counter on watchlists, while Morepen Laboratories Fundamental Analysis and peer comparison help place the move in context.
Morepen Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 102.49 |
| Previous Close | Rs 96.62 |
| Today's Move | Rs 5.87 (+6.08%) |
| Open | Rs 96.84 |
| High | Rs 102.9 |
| Low | Rs 96.07 |
| Turnover | Rs 6.11 crore |
| Market Capitalisation | Rs 5,314.6 crore |
| Market Cap Category | Mid Cap |
Morepen Laboratories Ltd. (MOREPENLAB) rose to Rs 102.49 from the previous close of Rs 96.62, a move of Rs 5.87 or 6.08%. The stock opened at Rs 96.84, reached a high of Rs 102.9, recorded a low of Rs 96.07.
Morepen Laboratories Share Price Today reflects a same-day gain of Rs 5.87, or 6.08%, with the stock finishing at Rs 102.49 after moving between a day low of Rs 96.07 and a day high of Rs 102.9. The opening price was Rs 96.84, so the session stayed above the open for most of the trading day. The available data confirms a clear price rise and a higher close, but it does not establish a company-specific trigger. For readers scanning Morepen Laboratories Share Price Live or Morepen Laboratories Share Price Update, today’s session is best read as a strong upward price move within the day’s range. Univest presents the move as verified market data rather than a speculative story.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,314.6 crore |
| P/E Ratio | 47.27x |
| P/B Ratio | 4.08x |
| ROE | 11.78% |
| ROCE | 15.48% |
| EPS | Rs 2.04 |
| Book Value Per Share | Rs 23.67 |
| Dividend Yield | 0.21% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 47.27x, P/B 4.08x, ROE 11.78%, ROCE 15.48%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 5314.6 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 47.27x, P/B at 4.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 15.48%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.04, book value per share of Rs 23.67, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.16x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 47.27x |
| Benchmark Median P/E | 31.16x |
| Benchmark Average P/E | 48.05x |
| Benchmark P/E Range | 3.36x to 397.25x |
| Company P/B Ratio | 4.08x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 11.78% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 15.48% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 5,314.6 crore |
| Benchmark Median Market Cap | Rs 664.09 crore |
Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 47.27x, which is above the benchmark median of 31.16x, a difference of +51.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 11.78%, which is below the benchmark median of 11.82%, a difference of -0.34%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 15.48%, which is above the benchmark median of 13.71%, a difference of +12.91%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,56,113.58 | 37.7 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,39,321.25 | 82.14 | 13.6 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,85,923.81 | 87.64 | 21.3 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,508.45 | 26.28 | 4.4 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,13,778.04 | 34.03 | 3.26 | 11.83 | 16 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 47.27x compared with the displayed peer median of 37.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.48% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 5,314.6 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- Morepen Laboratories Share Price rose 6.08% today to Rs 102.49, with a day gain of Rs 5.87.
- The stock closed above the previous close of Rs 96.62 and near the day high of Rs 102.9.
- Market capitalisation stood at Rs 5,314.6 Cr, which places the company above the same-industry median size.
- P/E of 47.27 and P/B of 4.08 are both above the same-industry medians of 31.16 and 2.71.
- EPS of Rs 2.04, book value of Rs 23.67 and dividend yield of 0.21% provide extra fundamental context.
About Morepen Laboratories
Morepen Laboratories Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The business context supplied here positions the company within a large listed pharma universe where valuation, earnings and profitability are often compared against peers rather than read in isolation. Morepen Laboratories Share Price is therefore tracked not only for the day’s move, but also for its place inside the broader Indian pharmaceutical landscape.
The supplied data does not include a detailed product or segment breakdown, so the visible analysis stays focused on market cap, earnings ratios, book value, dividend yield and peer benchmarks. For users scanning Morepen Laboratories Company News or Morepen Laboratories Stock Performance, the main takeaway is that the stock is priced with a valuation premium to several industry medians while remaining far smaller than many large listed peers. Univest presents the company profile as a factual foundation for further monitoring.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Morepen Laboratories Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. Univest brings Morepen Laboratories Share Price Today, Morepen Laboratories Stock News and Morepen Laboratories Stock Analysis together for quick reference without adding speculation. Users can also follow Morepen Laboratories NSE and Morepen Laboratories BSE context alongside sector and peer comparisons.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Morepen Laboratories Share Price rise today?
Ans. The supplied data confirms a 6.08% same-day rise to Rs 102.49, but it does not establish a company-specific catalyst. The move is supported by verified session data, including the day’s high, low, open and previous close.
What is Morepen Laboratories Share Price today?
Ans. Morepen Laboratories Share Price today is Rs 102.49. It rose Rs 5.87 from the previous close of Rs 96.62 and closed near the day high of Rs 102.9 after opening at Rs 96.84.
How much did Morepen Laboratories stock gain today?
Ans. Morepen Laboratories stock gained Rs 5.87, which equals 6.08% for the day. That move came within a range of Rs 96.07 to Rs 102.9, showing a clear upward session in the available market data.
What is the market cap of Morepen Laboratories?
Ans. Morepen Laboratories has a market capitalisation of Rs 5,314.6 Cr. Market cap indicates company size in the market and helps place the stock against sector peers, benchmark medians and average valuations.
How does Morepen Laboratories compare with industry valuation?
Ans. Morepen Laboratories has a P/E of 47.27 and a P/B of 4.08. Both are above the same-industry medians of 31.16 and 2.71, while P/E remains close to the industry average of 48.05.
What do Morepen Laboratories EPS and book value show?
Ans. EPS is Rs 2.04 and book value is Rs 23.67. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share. Both help frame Morepen Laboratories Share Price.
What do ROE and ROCE mean for Morepen Laboratories?
Ans. ROE for Morepen Laboratories is 11.78% and ROCE is 15.48%. ROE measures return on shareholder equity, while ROCE measures returns generated on capital employed, giving context to profitability and capital use.
How does Morepen Laboratories compare with pharma peers?
Ans. Morepen Laboratories trades at a P/E of 47.27, above several peers such as Sun Pharma, Zydus Lifesciences and Cipla, but below Divi’s Laboratories and Torrent Pharmaceuticals. Its profitability ratios sit in the middle of the set.
